Month: August 2022

Company announcement – No. 37 / 2022 Total number of shares and voting rights in Zealand Pharma at August 31, 2022 Copenhagen, DK and Boston, MA, August 31, 2022 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, in accordance with section 32 of the Danish Capital Markets Act, announces the total number of shares and voting rights in the Company at the end of a calendar month during which there have been changes to its share capital. In Company announcement No. 35/2022 from August 18, 2022, Zealand announced an increase in share capital relating to exercise of employee warrants. Following this announcement, the table below lists the total number of shares and voting rights in Zealand up to and including...

PITTSBURGH, Aug. 31, 2022 (GLOBE NEWSWIRE) — Montauk Renewables, Inc. (NASDAQ: MNTK) (the “Company”) announces the planned construction of a second renewable natural gas (“RNG”) processing facility at its Apex landfill gas project in Amsterdam, Ohio (the “Project”). The planned Project is being driven by projections in biogas feedstock availability from the host landfill over the next 12 to 18 months. The Company is targeting an approximate 40% increase in RNG processing capacity with the addition of the second facility. It is expected to add up to 2,100 MMBtu per day production capacity and expand the infrastructure for the conversion of LFG to RNG. The Project is expected to be completed in 2024, based on currently forecasted biogas feedstock volumes that are anticipated to be available from the host landfill at the time of commissioning. “Montauk...

BURLINGTON, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will participate in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on Wednesday, September 14, 2022, at 4:40 PM ET at the Sheraton New York Hotel, New York. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.CONTACT: Contact:Sandra Millar LeMaitre Vascular, Inc. +1-781-425-1686 smillar@lemaitre.com

XenpozymeTM (olipudase alfa-rpcp) approved by FDA as first disease-specific treatment for ASMD (non-CNS manifestations)   Paris, August 31, 2022. The U.S. Food and Drug Administration (FDA) has approved XenpozymeTM (olipudase alfa-rpcp) for the treatment of non-central nervous system (non-CNS) manifestations of acid sphingomyelinase deficiency (ASMD) in adult and pediatric patients. Xenpozyme is the first therapy indicated specifically for the treatment of ASMD, and is currently the only approved treatment for this disease. Bill SiboldExecutive Vice President, Head, Specialty Care at Sanofi “Sanofi teams have been dedicated to bringing hope to patients living with ASMD and their families. This is a devastating and extremely rare disease that affects both children and adults. The approval of Xenpozyme represents the culmination of bold...

Nokia CorporationStock Exchange Release31 August 2022 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 31.08.2022 Espoo, Finland – On 31 August 2022 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows:Trading venue (MIC Code) Number of shares Weighted average price / share, EUR*XHEL 236,366 4.94CEUX 3,617 4.95AQEU 3,459 4.95TQEX 3,058 4.95Total 246,500 4.94* Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU)...

Leading payroll provider for small and mid-sized businesses makes it easy for organizations of all sizes to offer competitive retirement plans with API integrations AUSTIN, Texas, Aug. 31, 2022 (GLOBE NEWSWIRE) — Asure Software, Inc., (Nasdaq: ASUR), a leading provider of cloud-based Human Capital Management (“HCM”) software solutions, today announced its payroll systems now feature direct integration with more than 80 401(k) providers. The time and expense required to maintain traditional options for providing employer-sponsored 401(k) plans have been a longtime barrier to entry for smaller employers. Asure is actively removing that barrier by making 401(k) plan delivery easier and more accessible for organizations with limited resources. Asure’s established integrations enable employers to sync their Asure payroll system and...

TORONTO, Aug. 31, 2022 (GLOBE NEWSWIRE) — McEwen Copper Inc., a subsidiary of McEwen Mining Inc. (NYSE: MUX) (TSX: MUX), is pleased to announce the closing of the third and final tranche of the previously announced private placement offering (the “Offering”) of up to 8,000,000 common shares of McEwen Copper Inc. priced at US$10.00 per common share. The third tranche is comprised of a $25 million investment by Rio Tinto’s copper leaching technology venture, Nuton (“Nuton” or the “Investor”), and $1.85 million from other investors. The total Offering has been increased to 8,185,000 common shares, with the amounts raised in the three tranches of the private placement totalling $81.85 million. McEwen Copper is well-funded to advance its Los Azules Project, located in the mining friendly province of San Juan, Argentina. The next milestones...

Liquidity Contract Windhof – August, 31st 2022 Sword Group – H1 Report of the Liquidity Agreement contracted with ODDO BHF from 01/01/2022 au 30/06/2022 Under the liquidity contract awarded by Sword Group to ODDO BHF, as of 30/06/2022, the following resources appeared on the account of liquidity: 13,820 shares €296,701 – Number of transactions executed during the semester at purchase: 1,271 – Number of transactions executed during the semester on sale: 984 – Volume exchanged over the semester upon purchase: 49,859 shares for an amount of €2,098,424 – Volume exchanged over the semester for sale: 39,843 shares for an amount of €1,769,407 As a reminder, during the last balance sheet of 31/12/2021, the following resources appeared in the liquidity account: 3,804 shares €625,718 The implementation of the...